LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,376 | +28.5% | 1,932 | +28.5% | 0.00% | – |
| Q2 2023 | $4,960 | +44990.9% | 1,503 | -53.2% | 0.00% | – |
| Q1 2023 | $11 | +10.0% | 3,211 | +14.8% | 0.00% | – |
| Q4 2022 | $10 | -100.0% | 2,797 | +8.3% | 0.00% | – |
| Q3 2022 | $23,000 | -11.5% | 2,582 | -21.3% | 0.00% | -100.0% |
| Q2 2022 | $26,000 | +2500.0% | 3,280 | +5025.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 64 | -25.6% | 0.00% | – |
| Q4 2021 | $1,000 | – | 86 | +8500.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 1 | -99.2% | 0.00% | – |
| Q2 2021 | $1,000 | -66.7% | 123 | -48.3% | 0.00% | – |
| Q1 2021 | $3,000 | -66.7% | 238 | -77.2% | 0.00% | -100.0% |
| Q1 2020 | $9,000 | – | 1,043 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 407,192 | $4,071,000 | 0.70% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 50,000 | $500,000 | 0.66% |
| Opaleye Management Inc. | 382,000 | $3,820,000 | 0.63% |
| Investors Financial Group, LLC | 29,600 | $296,000 | 0.16% |
| Wealth Advisors of Iowa, LLC | 11,760 | $178,000 | 0.09% |
| NEA Management Company, LLC | 526,663 | $5,267,000 | 0.07% |
| Marquette Asset Management, LLC | 8,919 | $89,000 | 0.02% |
| Blackstone Inc. | 468,145 | $4,681,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 52,543 | $522,000 | 0.01% |
| Jefferies Group LLC | 120,651 | $1,206,510 | 0.01% |